Effectiveness of Anti-Psychotic in GPs Setting (Serenity)
Evaluating the effectiveness of atypical antipsychotics in the community - a prospective, multicentre, observational study to evaluate the impact on Quality of Life of GP-based management of antipsychotic treatment in Belgium
|Study Design:||Time Perspective: Prospective|
|Official Title:||SERENITY: Evaluating the Effectiveness of Atypical Antipsychotics in the Community - a Prospective, Multicentre, Observational Study to Evaluate the Impact on Quality of Life of GP-Bases Management of Antipsychotic Treatment in Belgium.|
- to evaluate the patient's functioning, by measuring the Quality of Life. Quality of Life will be assessed by the Q-LES-Q-16 (PRO).
- The clinical efficacy & tolerability of atypical antipsychotics as assessed by the Clinical Global Impression(CGI) & Patient Global Impression of Change(PGIC)scores.
- The wellbeing of the patients taking atypical antipsychotics as assessed by the Sheehan Disability Scale(SDS)
|Study Start Date:||January 2007|
|Study Completion Date:||June 2008|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543088
Show 57 Study Locations
|Principal Investigator:||Pitchot W Pr||ULg|